Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:51 AM
Ignite Modification Date:
2025-12-26 @ 1:32 AM
NCT ID:
NCT01873833
Group ID:
EG000
Title:
Treatment (Chemotherapy, Lapatinib Ditosylate, Trastuzumab)
Description:
Patients receive capecitabine PO QD, cyclophosphamide PO QD, and lapatinib ditosylate PO QD on days 1-21 and trastuzumab IV on day 1. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
capecitabine: Given PO
cyclophosphamide: Given PO
lapatinib ditosylate: Given PO
trastuzumab: Given IV
laboratory biomarker analysis: Correlative studies
Deaths Number Affected:
5
Deaths Number At Risk:
None
Serious Number Affected:
5
Serious Number At Risk:
10
Other Number Affected:
10
Other Number At Risk:
10
Study:
NCT01873833
Results Section:
NCT01873833
Adverse Events Module:
NCT01873833